tiprankstipranks
aTyr Pharma (ATYR)
NASDAQ:ATYR
US Market
ATYR
aTyr Pharma
RESEARCH TOOLSreports

aTyr Pharma (ATYR) Income Statement

2,817 Followers

aTyr Pharma Income Statement

Last quarter (Q4 2025), aTyr Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, aTyr Pharma's net income was $-13.96M. See aTyr Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 190.00K$ 235.00K$ 353.00K$ 10.39M$ 0.00
Gross Profit
$ -1.36M$ 235.00K$ 353.00K$ 8.69M$ -1.30M
Operating Expenses
$ 76.26M$ 68.15M$ 55.27M$ 55.09M$ 32.71M
Depreciation and Amortization
$ 1.55M$ 1.54M$ 2.74M$ 1.70M$ 1.30M
EBITDA
$ -76.07M$ -66.37M$ -52.18M$ -44.71M$ -32.47M
Operating Income
$ -77.63M$ -67.91M$ -54.92M$ -46.40M$ -34.02M
Other Income/Expenses
$ 3.51M$ 3.89M$ 4.52M$ 1.06M$ 238.00K
Pretax Income
$ -74.12M$ -64.02M$ -50.40M$ -45.34M$ -33.78M
Net Income
$ -74.12M$ -64.02M$ -50.39M$ -45.34M$ -33.77M
Per Share Metrics
Basic EPS
$ -0.80$ -0.86$ -0.94$ -1.60$ -1.77
Diluted EPS
$ -0.80$ -0.86$ -0.94$ -1.60$ -1.77
Weighted Average Shares Outstanding
 92.99M 74.26M 53.61M 28.42M 19.08M
Weighted Average Shares Outstanding (Diluted)
 92.99M 74.26M 53.61M 28.42M 19.08M
Currency in USD

aTyr Pharma Earnings and Revenue History